These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19168193)

  • 1. Balancing the costs and benefits of opioid analgesics in the United States.
    Coffin PO
    Public Health; 2009 Feb; 123(2):147-8; discussion 149-50. PubMed ID: 19168193
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
    Birnbaum HG; White AG; Reynolds JL; Greenberg PE; Zhang M; Vallow S; Schein JR; Katz NP
    Clin J Pain; 2006 Oct; 22(8):667-76. PubMed ID: 16988561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction.
    White AG; Birnbaum HG; Rothman DB; Katz N
    Appl Health Econ Health Policy; 2009; 7(1):61-70. PubMed ID: 19558195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical correction needed in "Prescription Drug Abuse" article.
    Gelfand SG; Van Zee A
    Pain Physician; 2007 Mar; 10(2):382; author reply 382. PubMed ID: 17387362
    [No Abstract]   [Full Text] [Related]  

  • 5. Societal costs of prescription opioid abuse, dependence, and misuse in the United States.
    Birnbaum HG; White AG; Schiller M; Waldman T; Cleveland JM; Roland CL
    Pain Med; 2011 Apr; 12(4):657-67. PubMed ID: 21392250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U.S. county prevalence of retail prescription opioid sales and opioid-related hospitalizations from 2011 to 2014.
    Ghertner R
    Drug Alcohol Depend; 2019 Jan; 194():330-335. PubMed ID: 30472572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic costs of nonmedical use of prescription opioids.
    Hansen RN; Oster G; Edelsberg J; Woody GE; Sullivan SD
    Clin J Pain; 2011; 27(3):194-202. PubMed ID: 21178601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Societal economic benefits associated with an extended-release opioid with abuse-deterrent technology in the United States.
    Kirson NY; Shei A; White AG; Birnbaum HG; Ben-Joseph R; Rossiter LF; Michna E
    Pain Med; 2014 Sep; 15(9):1450-4. PubMed ID: 25041231
    [No Abstract]   [Full Text] [Related]  

  • 9. Opioid Dependence and Health Care Utilization After Decompression and Fusion in Patients With Adult Degenerative Scoliosis.
    Sharma M; Ugiliweneza B; Sirdeshpande P; Wang D; Boakye M
    Spine (Phila Pa 1976); 2019 Feb; 44(4):280-290. PubMed ID: 30015717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse Events.
    Chung CP; Callahan ST; Cooper WO; Dupont WD; Murray KT; Franklin AD; Hall K; Dudley JA; Stein CM; Ray WA
    Pediatrics; 2018 Aug; 142(2):. PubMed ID: 30012559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing the next crisis: six critical questions about the opioid epidemic that need answers.
    Scanlon DP; Hollenbeak CS
    Am J Manag Care; 2019 Jul; 25(13 Suppl):S234-S238. PubMed ID: 31361431
    [No Abstract]   [Full Text] [Related]  

  • 12. Tighter prescribing regulations drive illicit opioid sales.
    Hadland SE; Beletsky L
    BMJ; 2018 Jun; 361():k2480. PubMed ID: 29898950
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural Language Processing-Identified Problem Opioid Use and Its Associated Health Care Costs.
    Masters ET; Ramaprasan A; Mardekian J; Palmer RE; Gross DE; Cronkite D; Von Korff M; Carrell DS
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):106-115. PubMed ID: 30702378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Opioid Prescriptions to Physical Therapy Referral and Participation for Medicaid Patients with New-Onset Low Back Pain.
    Thackeray A; Hess R; Dorius J; Brodke D; Fritz J
    J Am Board Fam Med; 2017; 30(6):784-794. PubMed ID: 29180553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. County-Level Opioid Prescribing in the United States, 2015 and 2017.
    Guy GP; Zhang K; Schieber LZ; Young R; Dowell D
    JAMA Intern Med; 2019 Apr; 179(4):574-576. PubMed ID: 30742206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to the opioid epidemic: the economic burden on the healthcare system and impact on quality of life.
    Hagemeier NE
    Am J Manag Care; 2018 May; 24(10 Suppl):S200-S206. PubMed ID: 29851449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between state Medicaid expansion status and naloxone prescription dispensing.
    Sohn M; Talbert JC; Delcher C; Hankosky ER; Lofwall MR; Freeman PR
    Health Serv Res; 2020 Apr; 55(2):239-248. PubMed ID: 32030751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.
    Alley K; Singla A; Afzali A
    Inflamm Bowel Dis; 2019 Nov; 25(12):1990-1995. PubMed ID: 31087042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit.
    Xie L; Joshi AV; Schaaf D; Mardekian J; Harnett J; Shah ND; Baser O
    Pain Pract; 2014 Jun; 14(5):446-56. PubMed ID: 23809064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the Community-Prescribed Opioid Load: A Public Health Approach to the Opioid Epidemic.
    Lew J; Moore K
    J Opioid Manag; 2016; 12(4):235-7. PubMed ID: 27575823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.